Lydia Breckenridge

Lydia Breckenridge has been a Research Investigator at Bristol-Myers Squibb Co, New Brunswick, NJ since 2007. Before joining the Atomic Spectroscopy group in Analytical Research and Development at BMS, Lydia received her BS in chemistry from Virginia Tech in 2003 and a Ph.D. in Analytical Chemistry under Dr. James D.
Winefordner at the University of Florida in 2007. While at UFL, she concurrently earned a MS degree in Forensic Drug Chemistry under Dr. Ian Tebbitt. Her work at BMS involves the use of a broad range of atomic spectroscopic techniques, including inductively coupled plasma-atomic emission spectroscopy (ICP-AES), inductively coupled plasma-mass spectrometry (ICP-MS), atomic absorption spectroscopy (AAS) and laser ablation (LA)-ICP-MS for method development and metals analysis of a variety of pharmaceutical products. Lydia is also involved in developing laser-induced breakdown spectroscopy (LIBS) methods for a variety of pharmaceutical applications, including excipient and active pharmaceutical ingredient homogeneity determination and identification of counterfeit drug products.
Read More

Articles by Lydia Breckenridge